|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.27/-0.19
|
企业价值
3.01B
|
资产负债 |
每股账面净值
3.71
|
现金流量 |
现金流量率
--
|
损益表 |
收益
169.60M
|
每股收益
1.18
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/23 18:27 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions. |